Broadwood’s Surge: Institutional Buying Signals Confidence in STAAR Surgical Post‑Alcon Collapse
Broadwood Partners’ new stake in STAAR Surgical signals a potential undervaluation, as the firm backs the company’s return to core ophthalmic devices after a failed Alcon merger.
3 minutes to read